Heiner Wedemeyer

, Germany

Heiner Wedemeyer is Professor and Chairmen of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School since April 2020. He received his medical degree from the University of Goettingen, Germany in 1996 and subsequently started his training in Internal Medicine at Hannover Medical School in Germany. From 1998 to 2000, he was a research fellow in immunology at the Liver Diseases Branch, National Institutes of Health, Bethesda, USA. Since 2001, he completed his training in Internal Medicine and Gastroenterology at Hannover Medical School, where he became Professor of Medicine in 2011. In 2012 he became Associate Professor at Hannover Medical School (W2). In February 2018 he took the Chair Position of the Department of Gastroenterology and Hepatology at the Essen University Hospital before moving to Hannover. Professor Wedemeyer has been involved in the scientific coordination of the German Network of Competence on Viral Hepatitis (Hep-Net) and the German Liver Foundation for more than 15 years. Currently, he serves as the Managing Director of the German Hepatitis C-Registry. Heiner Wedemeyer is member of several scientific organizations and was Secretary General of the European Association for the Study of the Liver from 2009 to 2011. Professor Wedemeyer has a long-term research interest in liver diseases with a main focus on viral hepatitis, liver transplantation and hepatocellular carcinoma. He has been working on translational research projects with a focus on adaptive and innate immune responses and clinical virology. Heiner Wedemeyer has been principal investigator in numerous clinical trials, focusing on antiviral therapy and immunotherapy of viral hepatitis B, C, D and E. At Hannover Medical School, he initiated a variety of translational research projects which were funded by the EU, the German Research Foundation and the German Ministry for Research and Education. Heiner Wedemeyer has authored over 375 original articles; his current Hirsch-Index is 86 (google scholar; November 2018) and his work has been quoted more than 32.800 times. Heiner Wedemeyer has been leading the European Association for the Study of Liver as Secretary General and advised WHO. In addition, he has been coordinator of several national and European treatment guidelines for hepatitis B, C, D and E. Heiner Wedemeyer has received numerous awards including the Hans Popper Award of the International Association of the Study of the Liver in 2002, the Innovation Award of the German Medical Faculties (2011) and the Rudolph-Schoen-Awards (2011). His research has been funded by the Deutsche Forschungsgemeinschaft, the German Ministry of Research and Education, the European Union, the European Association for the Study of the Liver and the Bill and Melinda Gates Foundation.


Chair - Meet the expert - Hepatitis D: What should I do with my patients in 2020?
Meet the Experts
29 August 2020 10:00 - 10:30 More ...


48 weeks of high dose (10mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection 28 August 2020 12:15 - 12:30 More ...
Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study 29 August 2020 15:00 - 15:00 More ...